Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript)

Company Overview - Regeneron Pharmaceuticals, Inc. is participating in the BofA Securities 2025 Healthcare Conference, with key speakers including Marion McCourt, Executive Vice President of Commercial, and Ryan Crowe, Senior Vice President of Investor Relations and Strategic Analysis [1][2]. Financial Performance - The company reported challenges in the retina space but showed strength across its overall commercial portfolio in the first quarter results released two weeks prior to the conference [4]. Product Insights - EYLEA and EYLEA HD are experiencing typical seasonality headwinds associated with the first quarter, along with significant impacts from inventory for EYLEA two milligram [5].